4.8 Article

Panretinal Photocoagulation for Proliferative Diabetic Retinopathy

Journal

NEW ENGLAND JOURNAL OF MEDICINE
Volume 365, Issue 16, Pages 1520-1526

Publisher

MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMct0908432

Keywords

-

Funding

  1. Abbott Medical Optics
  2. Alimera Sciences
  3. Allergan
  4. Bausch Lomb
  5. ForSight Labs
  6. Genzyme
  7. Lumenis
  8. Notal Vision
  9. Novartis
  10. QLT
  11. Regeneron
  12. Genentech

Ask authors/readers for more resources

A 55-year-old man with a 20-year history of type 2 diabetes mellitus was referred to a retina specialist after noticing a few black floaters in his left eye for the preceding week. His glycated hemoglobin level was 8.2%. He had no history of laser treatment for proliferative diabetic retinopathy in either eye. Ophthalmoscopic examination of the right eye showed venous beading, intraretinal microvascular abnormalities, and no macular edema. Ophthalmoscopic examination of the left eye showed extensive neovascularization of the disk, consisting of new vessels extending beyond the optic disk in all directions (Fig. 1A). The retina specialist diagnosed severe nonproliferative diabetic retinopathy in the right eye and high-risk proliferative diabetic retinopathy in the left eye, with no macular edema in either eye. The specialist recommended prompt initiation of panretinal photocoagulation in the left eye.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available